Cellectis S.A.
NASDAQ:CLLSBiotechnology
Healthcare
$1.06 -0.65%
-$0.02 today
- Market cap
- $106.78M
- Beta
- 2.75
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.67
52W Low $1.35High $5.48
Volume 0.02M
Average 0.04M
Price history
Cellectis S.A. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-74.21%
Period high
$5.35
Period low
$0.93
Latest
$1.06
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 6-K | Nov 13, 2026 | Nov 13, 2026 | |
| 6-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13D/A | Nov 9, 2026 | Nov 9, 2026 | |
| 6-K | Nov 9, 2026 | Nov 9, 2026 | |
| 6-K | Oct 28, 2026 | Oct 28, 2026 | |
| 6-K | Sep 14, 2026 | Sep 14, 2026 | |
| 6-K | Sep 11, 2026 | Sep 11, 2026 | |
| 6-K/A | Sep 11, 2026 | Sep 11, 2026 | |
| 6-K | Sep 1, 2026 | Sep 1, 2026 | |
| S-8 | Aug 6, 2026 | Aug 6, 2026 | |
| 6-K | Aug 6, 2026 | Aug 6, 2026 | |
| 6-K | Aug 6, 2026 | Aug 6, 2026 | |
| 6-K | Jul 30, 2026 | Jul 30, 2026 | |
| 6-K/A | Jun 26, 2026 | Jun 26, 2026 | |
| 6-K | Jun 25, 2026 | Jun 25, 2026 |
Competitors
Who does Cellectis S.A. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CLLS's filings, answered from its disclosures.
What is the latest CLLS filing?
The latest filing shown is 6-K dated Nov 13, 2026.
How many recent filings does CLLS have?
Intrinsic Alpha currently shows 20 recent filings for CLLS.
Continue the stock analysis
Jump to another research area for this company.